Virco



  Virco is a biotech company located in Mechelen, Belgium. It provides a quantitative phenotype prediction for HIV resistance testing. The prediction is achieved by performing a search in a database of genotype-phenotype pairs and matching the mutations in the database with those of the sample of the patient (Nearest neighbor search). A phenotype is predicted which provides information on the resistance of the virus to treatment.

History

Virco was founded in 1995 by Rudi Pauwels (Rega Institute for Medical Research) and Johnson & Johnson.

References

  • Larder BA, Kemp SD, Hertogs K. Quantitative prediction of HIV-1 phenotypic drug resistance from genotypes: the virtual phenotype (VirtualPhenotype), Antiviral Therapy. 2000;5 (suppl 3):49.

See also
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Virco". A list of authors is available in Wikipedia.